Bristol-Myers Squibb Co. (NYSE: BMY) reported Q4 EPS of $0.53, $0.02 worse than the analyst estimate of $0.55. Revenue for the quarter came in at $5.45 billion versus the consensus estimate of $5.5 billion.

For earnings history and earnings-related data on Bristol-Myers Squibb Co. (BMY) click here.

Earnings